ZTS FY2025 SEC EDGAR DEF 14A #12 of 168 in industry

Zoetis Inc. CEO pay ratio

The CEO earned $19.0M in FY2025 against median worker pay of $80,592 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
NJ
Filing date
2026-04-08
Industry
Chemicals & Pharmaceuticals
Industry rank
#12/168

Data updated August 2026

Subscribe to Zoetis Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
236:1
High (Scale: 0–1000:1)
CEO pay
$19.0M
Median worker
$80,592

Answer first

Zoetis Inc.'s FY2025 CEO total of $19.0M ranks #185 of 1,423 complete filings; its 236:1 pay ratio ranks #263. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $80,592. Industry placement uses the FY2025 SIC-28 peer cohort (# 12 of 168, 93rd percentile - top 10% of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#185
$19.0M of 1,423 FY2025
Ratio rank
#263
236:1 of 1,423
Industry pct
93rd
top 10% of industry peers by pay ratio

How Zoetis Inc. ranks nationally

Zoetis Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$19,019,712 Top 13% higher than 87% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). Below this entry. $12,500,000–$15,000,000: 91 companies (6%). Below this entry. $15,000,000–$17,500,000: 88 companies (6%). Below this entry. $17,500,000–$20,000,000: 54 companies (4%). This entry sits in this band. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Zoetis Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($19.0M) against pay ratio (236:1) for Zoetis Inc. (marked) and its 4 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both7009393.010193975.713378558.516563141.319747724.131.3:190.4:1149.5:1208.6:1267.8:1CEO total payPay ratio (CEO : median worker)Zoetis Inc., CEO total pay: 19019712 · Pay ratio (CEO : median worker): 236:1Zoetis Inc.International Flavors & Fragrances Inc, CEO total pay: 15015892 · Pay ratio (CEO : median worker): 239:1International Flavors & Fragrances IncTrulieve Cannabis Corp., CEO total pay: 7588408 · Pay ratio (CEO : median worker): 243:1Trulieve Cannabis Corp.BeOne Medicines Ltd., CEO total pay: 17925268 · Pay ratio (CEO : median worker): 218:1BeOne Medicines Ltd.Teva Pharmaceutical Industries Ltd, CEO total pay: 19168709 · Pay ratio (CEO : median worker): 257:1Teva Pharmaceutical Industries Ltd
Zoetis Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Zoetis Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Zoetis Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
236:1
FY2025
vs prior FY
+19:1
from FY2024 217:1
CEO $ YoY
+11%
$19.0M latest
Filings shown
5
FY2021–2025
Zoetis Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $13.1M - $81,497 161:1 -
2022 $14.0M +6.9% $84,016 167:1 +6:1
2023 $15.3M +8.8% $74,848 204:1 +37:1
2024 $17.2M +12% $79,134 217:1 +13:1
2025 $19.0M +11% $80,592 236:1 +19:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1555280, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
236:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$19.0M
Companies in Industry
168
vs. Industry Median
Above
#12 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Zoetis Inc.: STEEP · PEAK pay ratio

Zoetis Inc.'s FY2025 ratio 236:1 ranks #12 of 168 Chemicals & Pharmaceuticals filers (93rd percentile). the CEO earned 236× the median employee ($80,592) in FY2025.

Median employee $80,592 (HIGH-MED); STEEP · PEAK stamps put about 236 median-wage years per CEO year.

CEO Total Pay

$19.0M

FY2025 Summary Compensation, well above median

Pay Ratio

236:1

Elevated vs. peers

Zoetis Inc. in the higher Chemicals & Pharmaceuticals third

Zoetis Inc.'s FY2025 ratio 236:1 ranks #12 of 168 Chemicals & Pharmaceuticals filers (93rd percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Zoetis Inc.'s $19.0M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #185 and ratio rank #263 split - treat 236:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$19.0M
Median Employee Pay
$80,592
Pay Ratio
236:1
Filing Date
2026-04-08

Company Info

Ticker
ZTS
CIK
1555280
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
NJ
View SEC filings →
SEC EDGAR DEF 14A for CIK 1555280, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Zoetis Inc.'s FY2025 ratio 236:1 ranks #12 of 168 Chemicals & Pharmaceuticals filers (93rd percentile).

Read with Zoetis Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps STEEP · PEAK · HIGH-MED.

Marathon Petroleum Corp · PEAK

ABS(ceo_total_comp) peer at $19.0M (Δ $34K lighter vs Zoetis Inc.); MID · ELITE-MED vs this page's STEEP · PEAK · HIGH-MED.
Madrigal Pharmaceuticals, Inc. · PEAK

ABS(ceo_total_comp) peer at $19.0M (Δ $60K lighter vs Zoetis Inc.); MODEST · ELITE-MED vs this page's STEEP · PEAK · HIGH-MED.
Carnival Corp Ltd. · PEAK

ABS(ceo_total_comp) peer at $18.9M (Δ $132K lighter vs Zoetis Inc.); MEGA · LOW-MED vs this page's STEEP · PEAK · HIGH-MED.
Churchill Downs Inc · PEAK

ABS(ceo_total_comp) peer at $19.2M (Δ $153K heavier vs Zoetis Inc.); EXTREME · LOW-MED vs this page's STEEP · PEAK · HIGH-MED.
International Flavors & Fragrances Inc (SIC 28 pole)

International Flavors & Fragrances Inc stamps STEEP · PEAK nearest in-SIC by ABS(pay_ratio) to Zoetis Inc.'s STEEP filing.
National dual ranks · #185/#263

Zoetis Inc.'s FY2025 package sits #185 by CEO dollars and #263 by ratio under PEAK · STEEP.
Comp structure · PEAK

Zoetis Inc.'s PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for Zoetis Inc. (CIK 1555280), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.